- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy - Abstract
September 20, 2012
A retrospective review of UroVysion FISH interpretations over 8.6 years: A major shift in the patient test population - Abstract
September 20, 2012
Prospective evaluation of MRI, (11)C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer - Abstract
September 19, 2012
Bladder cancer radiotherapy margins: A comparison of daily alignment using skin, bone or soft tissue - Abstract
September 19, 2012
Current status of robot-assisted radical cystectomy for bladder cancer - Abstract
September 18, 2012
Statin use and the risk of bladder cancer: A population-based case-control study - Abstract
September 18, 2012
Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: Does it reduce recurrences? - Abstract
September 18, 2012
Recent advances in urinary bladder cancer detection - Abstract
September 17, 2012
Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer - Abstract
September 14, 2012
Strategies to prevent progression of high-risk bladder cancer at initial diagnosis - Abstract
September 14, 2012
Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: A single center experience - Abstract
September 13, 2012
Robotic assisted radical cystectomy: Oncological safety - Abstract
September 13, 2012
Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia - Abstract
September 13, 2012
Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer - Abstract
September 12, 2012